These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12372506)

  • 1. Bridged bicyclic vasopressin receptor antagonists with V(2)-selective or dual V(1a)/V(2) activity.
    Dyatkin AB; Hoekstra WJ; Hlasta DJ; Andrade-Gordon P; de Garavilla L; Demarest KT; Gunnet JW; Hageman W; Look R; Maryanoff BE
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3081-4. PubMed ID: 12372506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of azabicyclo[3.2.1]octane derivatives as potent mixed vasopressin antagonists.
    Crombie AL; Antrilli TM; Campbell BA; Crandall DL; Failli AA; He Y; Kern JC; Moore WJ; Nogle LM; Trybulski EJ
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3742-5. PubMed ID: 20471258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological evaluation of 5-(4-biphenyl)-3-methyl-4-phenyl-1,2,4-triazole derivatives as a novel class of selective antagonists for the human vasopressin V(1A) receptor.
    Kakefuda A; Suzuki T; Tobe T; Tsukada J; Tahara A; Sakamoto S; Tsukamoto S
    J Med Chem; 2002 Jun; 45(12):2589-98. PubMed ID: 12036368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antihypertensive activity of 4-(diazabicyclo[4.1.0]-heptenyloxy)benzopyran derivatives and their analogues.
    Horino H; Mimura T; Kagechika K; Ohta M; Kubo H; Kitagawa M
    Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):602-9. PubMed ID: 9579035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 2-phenyl-4'-[(2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl]benzanil ide derivatives.
    Matsuhisa A; Tanaka A; Kikuchi K; Shimada Y; Yatsu T; Yanagisawa I
    Chem Pharm Bull (Tokyo); 1997 Nov; 45(11):1870-4. PubMed ID: 9396163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity study of novel tricyclic benzazepine arginine vasopressin antagonists.
    Sum FW; Dusza J; Santos ED; Grosu G; Reich M; Du X; Albright JD; Chan P; Coupet J; Ru X; Mazandarani H; Saunders T
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2195-8. PubMed ID: 12798333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esters of N-(2-hydroxy-1,1-dimethylethyl)-1,7,7-trimethylbicyclo[2.2.1] heptan-2-exo-amine with hypotensive activity.
    Bondavalli F; Bruno O; Ranise A; Schenone P; Susanna V; Lisa M; Maione S; Marmo E
    Farmaco Sci; 1987 Dec; 42(12):947-53. PubMed ID: 3449394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-substituted 4,7,7-trimethyl-3-(1-piperidinyl)bicyclo-[2.2.1]hept-2-ene 2-carboxamides and 2-carbothioamides with hypotensive activity.
    Ranise A; Bondavalli F; Schenone P; Berrino L; Matera C; Persico N; Romano AR; Marmo E
    Farmaco Sci; 1985 Feb; 40(2):120-3. PubMed ID: 3996581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly constrained bicyclic VLA-4 antagonists.
    Chang LL; Truong Q; Doss GA; MacCoss M; Lyons K; McCauley E; Mumford R; Forrest G; Vincent S; Schmidt JA; Hagmann WK
    Bioorg Med Chem Lett; 2007 Feb; 17(3):597-601. PubMed ID: 17118652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine vasopressin enhances GABAergic inhibition of cardiac parasympathetic neurons in the nucleus ambiguus.
    Wang J; Irnaten M; Venkatesan P; Evans C; Mendelowitz D
    Neuroscience; 2002; 111(3):699-705. PubMed ID: 12031355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,3,3-Trimethyl-N-(2-pyridyl)-2-oxabicyclo[2.2.2]octan-6-amine derivatives with hypotensive and other activities.
    Mariani E; Bruno O; Schenone P; De Santis D; Di Mauro G; Marmo E
    Farmaco Sci; 1986 Jun; 41(6):454-63. PubMed ID: 3743741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-covalent thrombin inhibitors featuring P3-heterocycles with P1-bicyclic arginine surrogates.
    Cui JJ; Araldi GL; Reiner JE; Reddy KM; Kemp SJ; Ho JZ; Siev DV; Mamedova L; Gibson TS; Gaudette JA; Minami NK; Anderson SM; Bradbury AE; Nolan TG; Semple JE
    Bioorg Med Chem Lett; 2002 Oct; 12(20):2925-30. PubMed ID: 12270176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent nonpeptide vasopressin receptor antagonists based on oxazino- and thiazinobenzodiazepine templates.
    Matthews JM; Hoekstra WJ; Dyatkin AB; Hecker LR; Hlasta DJ; Poulter BL; Andrade-Gordon P; de Garavilla L; Demarest KT; Ericson E; Gunnet JW; Hageman W; Look R; Moore JB; Reynolds CH; Maryanoff BE
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2747-52. PubMed ID: 15125926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular and renal effects of vasopressin and its antagonists in conscious rats with chronic myocardial infarction; evidence for receptor shift.
    Lankhuizen IM; van Veghel R; Saxena PR; Schoemaker RG
    Eur J Pharmacol; 2001 Jul; 423(2-3):195-202. PubMed ID: 11448485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoethers of (+)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]-octan-6-hydroxyimine with hypotensive activity. II.
    Bondavalli F; Bruno O; Ranise A; Schenone P; Filippelli A; Marrazzo R; Di Guglielmo R; Marmo E
    Farmaco Sci; 1986 Aug; 41(8):630-6. PubMed ID: 2874996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro characterisation of a nonpeptide vasopressin V(1A) and V(2) receptor antagonist (YM087) in the rat.
    Risvanis J; Naitoh M; Johnston CI; Burrell LM
    Eur J Pharmacol; 1999 Sep; 381(1):23-30. PubMed ID: 10528130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 4,5-diphenyl-1,2,4-triazole derivatives as a novel class of selective antagonists for the human V(1A) receptor.
    Kakefuda A; Suzuki T; Tobe T; Tahara A; Sakamoto S; Tsukamoto Si
    Bioorg Med Chem; 2002 Jun; 10(6):1905-12. PubMed ID: 11937348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoethers of 1,3,3-trimethyl-5-(phenylmethylene)-2-oxabicyclo[2.2.2]octan-6-h ydroxy imine with antiarrhythmic activity.
    Mariani E; Bargagna A; Longobardi M; Schenone P; Russo S; Filippelli W; Molinario L; Marmo E
    Farmaco Sci; 1988 Nov; 43(11):879-86. PubMed ID: 3251782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 4'-[5-(substituted methylidene)-2,3,4,5-tetrahydro-1H-1-ben zoazepine-1-carbonyl]benzanilide and 4'-[5-(substituted methyl)-2,3-dihydro-1H-1-benzoazepine-1- carbonyl]benzanilide derivatives.
    Matsuhisa A; Kikuchi K; Sakamoto K; Yatsu T; Tanaka A
    Chem Pharm Bull (Tokyo); 1999 Mar; 47(3):329-39. PubMed ID: 10212383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of VP-343, a novel selective vasopressin V2 receptor antagonist, in rats.
    Naito A; Ohtake Y; Hasegaw H; Fukaya AY; Kurasawa T; Naito K; Matsukawa H; Oguma T; Ezure Y; Tsuriya Y; Tanaka H; Koike K; Shigenobu K
    Biol Pharm Bull; 2000 Feb; 23(2):182-9. PubMed ID: 10706381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.